Ketofol is one of 65 small molecule programs targeting Sedation. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
167 competitors in Delirium
Victoza
Ritalin
Ketofol
Physostigmine
Rozerem
Inapsine
Anerem
Spravato
Raldesy
Bridion
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details